62 related articles for article (PubMed ID: 12800980)
1. CDK2 is involved in the S-phase lengthening induced by glucocorticoids in normal human lymphocytes.
Peiretti A; Baghdassarian N; Gerland LM; Ffrench P; Bryon PA; Magaud JP; Ffrench M
Eur J Cell Biol; 2003 May; 82(5):253-61. PubMed ID: 12800980
[TBL] [Abstract][Full Text] [Related]
2. Involvement of p27Kip1 in the G1- and S/G2-phase lengthening mediated by glucocorticoids in normal human lymphocytes.
Baghdassarian N; Peiretti A; Devaux E; Bryon PA; Ffrench M
Cell Growth Differ; 1999 Jun; 10(6):405-12. PubMed ID: 10392902
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids induce G1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell cycle regulatory proteins.
Baghdassarian N; Catallo R; Mahly MA; Ffrench P; Chizat F; Bryon PA; Ffrench M
Exp Cell Res; 1998 May; 240(2):263-73. PubMed ID: 9596999
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
5. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
[TBL] [Abstract][Full Text] [Related]
6. RhoA stimulates IEC-6 cell proliferation by increasing polyamine-dependent Cdk2 activity.
Guo H; Ray RM; Johnson LR
Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G704-13. PubMed ID: 12816757
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.
Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R
Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847
[TBL] [Abstract][Full Text] [Related]
8. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
Cereseto A; Washington Parks R; Rivadeneira E; Franchini G
Oncogene; 1999 Apr; 18(15):2441-50. PubMed ID: 10229195
[TBL] [Abstract][Full Text] [Related]
9. cAMP-dependent reorganization of the Cajal bodies and splicing machinery in cultured Schwann cells.
Fernandez R; Pena E; Navascues J; Casafont I; Lafarga M; Berciano MT
Glia; 2002 Dec; 40(3):378-88. PubMed ID: 12420317
[TBL] [Abstract][Full Text] [Related]
10. Insensitivity to growth inhibition by TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells.
Cipriano SC; Chen YQ
Oncogene; 1998 Sep; 17(12):1549-56. PubMed ID: 9794232
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
Gong J; Ammanamanchi S; Ko TC; Brattain MG
Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line.
Aranha O; Wood DP; Sarkar FH
Clin Cancer Res; 2000 Mar; 6(3):891-900. PubMed ID: 10741713
[TBL] [Abstract][Full Text] [Related]
13. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
Morris TA; DeLorenzo RJ; Tombes RM
Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
[TBL] [Abstract][Full Text] [Related]
14. Hyperoxia induces S-phase cell-cycle arrest and p21(Cip1/Waf1)-independent Cdk2 inhibition in human carcinoma T47D-H3 cells.
Bilodeau JF; Faure R; Piedboeuf B; Mirault ME
Exp Cell Res; 2000 May; 256(2):347-57. PubMed ID: 10772807
[TBL] [Abstract][Full Text] [Related]
15. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of the synthesis and activity of the major cyclin-dependent kinases, p34cdc2, p33cdk2, and p34cdk4, during cell cycle entry and progression in normal human T lymphocytes.
Lucas JJ; Szepesi A; Domenico J; Tordai A; Terada N; Gelfand EW
J Cell Physiol; 1995 Nov; 165(2):406-16. PubMed ID: 7593219
[TBL] [Abstract][Full Text] [Related]
17. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
18. Loss of cell cycle control by deregulation of cyclin-dependent kinase 2 kinase activity in Evi-1 transformed fibroblasts.
Kilbey A; Stephens V; Bartholomew C
Cell Growth Differ; 1999 Sep; 10(9):601-10. PubMed ID: 10511310
[TBL] [Abstract][Full Text] [Related]
19. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
Benaud CM; Dickson RB
Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
[TBL] [Abstract][Full Text] [Related]
20. Differential modulation of cyclin-dependent kinase inhibitor p27Kip1 by negative signaling via the antigen receptor of B cells and positive signaling via CD40.
Han H; Nomura T; Honjo T; Tsubata T
Eur J Immunol; 1996 Oct; 26(10):2425-32. PubMed ID: 8898956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
